Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 4 , Pages 669-694 , December 2008

Hyperthermia during anaesthesia and intensive care unit stay

  • Rainer Lenhardt, MD (Associate Professor)

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Anesthesiology & Perioperative Medicine, University Hospital, 530 S. Jackson St., Louisville, KY 40202, USA. Tel.: +1 502 852 3122; Fax: +1 502 852 2610.
  • Martin Grady, MD (Staff Anesthesiologist)

      Affiliations

    • Tel.: +1 216 445 6500; Fax: 1 216 444 6135.
  • Andrea Kurz, MD (Vice Chair)

      Affiliations

    • Tel.: +1 216 445 9924; Fax: 1 216 444 6135.

References 

  1. Guyton AC, Hall J. Textbook of Medical Physiology. Philadelphia: W.B. Sanders; 2001;
  2. Schafer J. Body temperature regulation. In:  Johnson LR,  Byrne JH editor. Essential Medical Physiology. Philadelphia: Lippincott, Willliams and Wilkins; 1998;p. 815–824
  3. Mackowiak PA, Wasserman SS, Levine MM. A critical appraisal of 98.6°F, the upper limit of the normal body temperature, and other legacies of Carl Reinhold August Wunderlich. The Journal of the American Medical Association. 1992;268:1578–1580
  4. ACCP/SCCM Consensus Conference Committee . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101:1644–1655
  5. Saper CB, Breder CD. Neurologic basis of fever. The New England Journal of Medicine. 1994;330:1880–1886
  6. Simon HB. Hyperthermia. The New England Journal of Medicine. 1993;329:483–487
  7. Lenhardt R, Negishi C, Sessler DI, et al. The effect of pyrogen administration on sweating and vasoconstriction thresholds during desflurane anesthesia. Anesthesiology. 1999;90:1587–1595
  8. Styrt B, Sugarman B. Antipyresis and fever. Archives of Internal Medicine. 1990;150:1589–1597
  9. Romanovsky AA, Szekely M. Fever and hypothermia: two adaptive thermoregulatory responses to systemic inflammation. Medical Hypotheses. 1998;50:219–226
  10. Cunha BA, Shea KW. Fever in the intensive care unit. Infectious Disease Clinics of North America. 1996;10:185–209
  11. McGowan JE, Rose RC, Jacobs NF, et al. Fever in hospitalized patients. With special reference to the medical service. The American Journal of Medicine. 1987;82:580–586
  12. Wunderlich, CRA. Das Verhalten von Eigenwärme in Krankheiten. Leipzig; 1868.
  13. O'Grady NP, Barie PS, Bartlett J, et al. Practice parameters for evaluating new fever in critically ill adult patients. Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine in collaboration with the Infectious Disease Society of America. Critical Care Medicine. 1998;26:392–408
  14. Mackowiak PA, Boulant JA. Fever's glass ceiling. Clinical Infectious Diseases. 1996;22:525–536
  15. IUPS Thermal Commission . Glossary of terms for thermal physiology (2nd edition). European Journal of Physiology. 1987;410:567–587
  16. Banks WA, Kastin AJ, Durham DA. Bidirectional transport of interleukin-1 alpha across the blood-brain barrier. Brain Research Bulletin. 1989;23:433–437
  17. Blatteis C. Role of the OVLT in the febrile response to circulating pyrogens. Progress in Brain Research. 1992;91:409–412
  18. Watkins LR, Goehler LE, Relton JK, et al. Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neuroscience Letters. 1995;183:27–31
  19. Banks W, Plotkin S, Kastin A. Permeability of the blood-brain barrier to soluble cytokine receptors. Neuroimmunomodulation. 1995;2:161–165
  20. Sitt J. Prostaglandine E as a mediator of the febrile response. The Yale Journal of Biology and Medicine. 1986;59:137–149
  21. Ivanov AI, Romanovsky AA. Prostaglandin E2 as a mediator of fever: synthesis and catabolism. Frontiers in Bioscience. 2004;9:1977–1993
  22. Fleshner M, Goehler LE, Hermann J, et al. Interleukin-1 beta induced corticosterone elevation and hypothalamic NE depletion is vagally mediated. Brain Research Bulletin. 1995;37:605–610
  23. Leslie R, Reynolds J, Lawes I. Central connections of the nucleus of the vagus nerve. In:  Ritter R,  Ritter S,  Barnes C editor. Neuroanatomy and physiology of the abdominal vagal afferents. Ann Arbor: CRC Press; 1992;p. 81–98
  24. Blatteis C, Sehic E. Fever: how may circulating pyrogens signal the brain?. News in Physiological Sciences. 1997;12:1–9
  25. Blatteis CM. The onset of fever: new insights into its mechanism. Progress in Brain Research. 2007;162:3–14
  26. Blatteis CM, Li S, Li Z, et al. Cytokines, PGE2 and endotoxic fever: a re-assessment. Prostaglandins & Other Lipid Mediators. 2005;76:1–18
  27. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. The New England Journal of Medicine. 1993;328:106–113
  28. Dinarello CA, Cannon JG, Mancilla J, et al. Interleukin-6 as an endogenous pyrogen: induction of prostaglandin E2 in brain but not in peripheral blood mononuclear cells. Brain Research. 1991;562:199–206
  29. Nakashima T, Hori T, Kuriyama K, Matsuda T. Effects of interferon-alpha on the activity of preoptic thermosensitive neurons in tissue slices. Brain Research. 1988;454:361–367
  30. Davatelis G, Wolpe SD, Sherry B, et al. Macrophage inflammatory protein-1: a prostaglandin-independent endogenous pyrogen. Science. 1989;243:1066–1068
  31. Fiorentino DF, Zlotnik A, Vieira P, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. Journal of Immunology. 1991;146:3444–3451
  32. Fiorentino DF, Zlotnik A, Mosmann TR, et al. IL-10 inhibits cytokine production by activated macrophages. Journal of Immunology. 1991;147:3815–3822
  33. Nava F, Calapai G, Facciola G, et al. Effects of interleukin-10 on water intake, locomotory activity, and rectal temperature in rat treated with endotoxin. International Journal of Immunopharmacology. 1997;19:31–38
  34. Pittman QJ, Wilkinson MF. Central arginine vasopressin and endogenous antipyresis. Canadian Journal of Physiology and Pharmacology. 1992;70:786–790
  35. Morrow LE, McClellan JL, Conn CA, Kluger MJ. Glucocorticoids alter fever and IL-6 responses to psychological stress and to lipopolysaccharide. The American Journal of Physiology. 1993;264:R1010–R1016
  36. Mier JW, Vachino G, Van Der Meer JWM, et al. Induction of circulating tumor necrosis factor (TNF-alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients. Journal of Clinical Immunology. 1988;8:426–436
  37. Dinarello CA, Cannon JG, Wolff SM, et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. The Journal of Experimental Medicine. 1986;163:1433–1450
  38. Klir JJ, McClellan JL, Kozak W, et al. Systemic but not central administration of tumor necrosis factor-alpha attenuates LPS-induced fever in rats. The American Journal of Physiology. 1995;268:R480–R486
  39. Leon LR. Invited review: cytokine regulation of fever: studies using gene knockout mice. Journal of Applied Physiology. 2002;92:2648–2655
  40. Kluger MJ. The evolution and adaptive value of fever. American Scientist. 1978;66:38–43
  41. Kluger MJ. Is fever beneficial?. The Yale Journal of Biology and Medicine. 1986;59:89–95
  42. Bernheim HA, Bodel PT, Askenase PW, Atkins E. Effects of fever on host defence mechanisms after infection in the lizard Dipsosaurus dorsalis. British Journal of Experimental Pathology. 1978;59:76–84
  43. Blatteis CM. Endotoxic fever: new concepts of its regulation suggest new approaches to its management. Pharmacology & Therapeutics. 2006;111:194–223
  44. Bennett IL, Nicastri A. Fever as a mechanism of resistance. Bacteriological Reviews. 1960;24:16–34
  45. Duff GW, Durum SK. Fever and immunoregulation: hyperthermia, interleukins 1 and 2, and T-cell proliferation. The Yale Journal of Biology and Medicine. 1982;55:437–442
  46. Kluger MJ, Ringler DH, Anver MR. Fever and survival. Science. 1975;188:166–168
  47. Dieing A, Ahlers O, Hildebrandt B, et al. The effect of induced hyperthermia on the immune system. Progress in Brain Research. 2007;162:137–152
  48. Field SB. Hyperthermia in the treatment of cancer. Physics in Medicine and Biology. 1987;32:789–811
  49. Falk MH, Issels RD. Hyperthermia in oncology. International Journal of Hyperthermia. 2001;17:1–18
  50. Engin K, Tupchong L, Waterman FM, et al. Multiple field hyperthermia combined with radiotherapy in advanced carcinoma of the breast. International Journal of Hyperthermia. 1994;10:587–603
  51. Pennypacker C, Nys N, Perelson A, et al. Localized or system in vivo heat-inactivation of human immunodeficiency virus (HIV): a mathematical analysis. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1995;8:321–329
  52. Rowell LB. Active neurogenic vasodilation in man. In:  Vanhoutte P,  Leusen I editor. Vasodilatation. New York: Raven Press; 1981;p. 1–17
  53. Rowell LB. Cardiovascular aspects of human thermoregulation. Circulation Research. 1983;52:367–379
  54. Giesbrecht GG, Sessler DI, Mekjavic IB, et al. Treatment of immersion hypothermia by direct body-to-body contact. Journal of Applied Physiology. 1994;76:2373–2379
  55. Detry J-MR, Brengelmann GL, Rowell LB, Wyss C. Skin and muscle components of forearm blood flow in directly heated resting man. Journal of Applied Physiology. 1972;32:506–511
  56. Rowell LB. Human Circulation Regulation During Physical Stress. New York: Oxford University Press; 1986;
  57. Brandom BW. Genetics of malignant hyperthermia. Scientific World Journal. 2006;6:1722–1730
  58. Haggendal J, Jonsson L, Carlsten J. The role of sympathetic activity in initiating malignant hyperthermia. Acta Anaesthesiologica Scandinavica. 1990;34:677–682
  59. Williams CH, Dozier SE, Buzello W, et al. Plasma levels of norepinephrine and epinephrine during malignant hyperthermia in susceptible pigs. Journal of Chromatography. 1985;344:71–80
  60. Khan M, Farver D. Recognition, assessment and management of neuroleptic malignant syndrome. South Dakota Journal of Medicine. 2000;53:395–400
  61. Washington D, Sessler DI, Moayeri A, et al. Thermoregulatory responses to hyperthermia during isoflurane anesthesia in humans. Journal of Applied Physiology. 1993;74:82–87
  62. Greif R, Laciny S, Rajek AM, et al. Neither nalbuphine nor atropine posses special antishivering activity. Anesthesia and Analgesia. 2001;93:620–627
  63. Boudet J, Qing W, Boyer-Chammard A, et al. Dose-response effects of atropine in human volunteers. Fundamental & Clinical Pharmacology. 1991;5:635–640
  64. Cadarette BS, Levine L, Rock PB, et al. Effects of atropine on thermoregulatory responses to exercise in different environments. Aviation, Space, and Environmental Medicine. 1986;57:1050–1055
  65. Ginsberg MD, Hertzman M, Schmidt-Nowara WW. Amphetamine intoxication with coagulopathy, hyperthermia, and reversible renal failure. A syndrome resembling heatstroke. Annals of Internal Medicine. 1970;73:81–85
  66. Dar KJ, McBrien ME. MDMA induced hyperthermia: report of a fatality and review of current therapy. Intensive Care Medicine. 1996;22:995–996
  67. Marzuk PM, Tardiff K, Leon AC, et al. Ambient temperature and mortality from unintentional cocaine overdose. The Journal of the American Medical Association. 1998;279:1795–1800
  68. Crandall CG, Vongpatanasin W, Victor RG. Mechanism of cocaine-induced hyperthermia in humans. Annals of Internal Medicine. 2002;136:785–791
  69. Astrup A, Bulow J, Madsen J, Christensen NJ. Contribution of BAT and skeletal muscle to thermogenesis induced by ephedrine in man. The American Journal of Physiology. 1985;248:E507–E515
  70. Makisumi T, Yoshida K, Watanabe T, et al. Sympatho-adrenal involvement in methamphetamine-induced hyperthermia through skeletal muscle hypermetabolism. European Journal of Pharmacology. 1998;363:107–112
  71. Armstrong LE, Crago AE, Adams R, et al. Whole-body cooling of hyperthermic runners: comparison of two field therapies. The American Journal of Emergency Medicine. 1996;14:355–358
  72. Negishi C, Lenhardt R, Sessler DI, et al. Desflurane reduces the febrile response to administration of interleukin-2. Anesthesiology. 1998;88:1162–1169
  73. Lenhardt R, Negishi C, Sessler DI, et al. Paralysis only slightly reduces the febrile response to interleukin-2 during isoflurane anesthesia. Anesthesiology. 1998;89:648–656
  74. Negishi C, Kim JS, Lenhardt R, et al. Alfentanil reduces the febrile response to interleukin-2 in humans. Critical Care Medicine. 2000;28:1295–1300
  75. Negishi C, Lenhardt R, Ozaki M, et al. Opioids inhibit febrile responses in humans, whereas epidural analgesia does not: an explanation for hyperthermia during epidural analgesia. Anesthesiology. 2001;94:218–222
  76. Bredtmann RD, Herden HN, Teichmann W, et al. Epidural analgesia in colonic surgery: results of a randomized prospective study. The British Journal of Surgery. 1990;77:638–642
  77. Lieberman E, O'Donoghue C. Unintended effects of epidural analgesia during labor: a systematic review. American Journal of Obstetrics and Gynecology. 2002;186:S31–S68
  78. Philip J, Alexander JM, Sharma SK, et al. Epidural analgesia during labor and maternal fever. Anesthesiology. 1999;90:1271–1275
  79. Lieberman E, Lang JM, Frigoletto F, et al. Epidural analgesia, intrapartum fever, and neonatal sepsis evaluation. Pediatrics. 1997;99:415–419
  80. Kaul B, Vallejo M, Ramanathan S, Mandell G. Epidural labor analgesia and neonatal sepsis evaluation rate: a quality improvement study. Anesthesia and Analgesia. 2001;93:986–990
  81. Palanisamy A, Hepner DL, Segal S. Fever, epidurals, and inflammation: a burning issue. Journal of Clinical Anesthesia. 2007;19:165–167
  82. Larue F, Labaille T, Mazoit X, et al. Anesthesie peridurale et surveillance de la temperature au cours du travail. Annales Francaises d'Anesthesie et de Reanimation. 1987;23:R163
  83. Fusi L, Steer PJ, Maresh MJ, Beard RW. Maternal pyrexia associated with the use of epidural analgesia in labour. Lancet. 1989;1:1250–1252
  84. Camann WR, Hortvet LA, Hughes N, et al. Maternal temperature regulation during extradural analgesia for labour. British Journal of Anaesthesia. 1991;67:565–568
  85. Goetzl L, Rivers J, Zighelboim I, et al. Intrapartum epidural analgesia and maternal temperature regulation. Obstetrics and Gynecology. 2007;109:687–690
  86. Leighton BL, Halpern SH. The effects of epidural analgesia on labor, maternal, and neonatal outcomes: a systematic review. American Journal of Obstetrics and Gynecology. 2002;186:S69–S77
  87. Joseph KS, Young DC, Dodds L, et al. Changes in maternal characteristics and obstetric practice and recent increases in primary cesarean delivery. Obstetrics and Gynecology. 2003;102:791–800
  88. Roy RP. A Darwinian view of obstructed labor. Obstetrics and Gynecology. 2003;101:397–401
  89. Gonen R, Korobochka R, Degani S, Gaitini L. Association between epidural analgesia and intrapartum fever. American Journal of Perinatology. 2000;17:127–130
  90. Smulian JC, Bhandari V, Vintzileos AM, et al. Intrapartum fever at term: serum and histologic markers of inflammation. American Journal of Obstetrics and Gynecology. 2003;188:269–274
  91. Frank SM, Kluger MJ, Kunkel SL. Elevated thermostatic setpoint in postoperative patients. Anesthesiology. 2000;93:1426–1431
  92. Lieberman E, Eichenwald E, Mathur G, et al. Intrapartum fever and unexplained seizures in term infants. Pediatrics. 2000;106:983–988
  93. Lieberman E, Lang J, Richardson DK, et al. Intrapartum maternal fever and neonatal outcome. Pediatrics. 2000;105:8–13
  94. Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birth weight. The Journal of the American Medical Association. 1997;278:207–211
  95. Impey L, Greenwood C, MacQuillan K, et al. Fever in labour and neonatal encephalopathy: a prospective cohort study. British Journal of Obstetrics and Gynecology. 2001;108:594–597
  96. Banerjee S, Steer PJ. The rise in maternal temperature associated with regional analgesia in labour is harmful and should be treated. International Journal of Obstetric Anesthesia. 2003;12:280–284
  97. Eltzschig HK, Lieberman ES, Camann WR. Regional anesthesia and analgesia for labor and delivery. The New England Journal of Medicine. 2003;348:319–332
  98. Finster M. Fever and infection during parturition: a preanesthetic or a postanesthetic problem?. Journal of Clinical Anesthesia. 2003;15:409–410
  99. Goetzl L, Rivers J, Evans T, et al. Prophylactic acetaminophen does not prevent epidural fever in nulliparous women: a double-blind placebo-controlled trial. Journal of Perinatology. 2004;24:471–475
  100. Goetzl L, Zighelboim I, Badell M, et al. Maternal corticosteroids to prevent intrauterine exposure to hyperthermia and inflammation: a randomized, double-blind, placebo-controlled trial. American Journal of Obstetrics and Gynecology. 2006;195:1031–1034
  101. Impey L, MacQuillan K, Robson M. Epidural analgesia need not increase operative delivery rates. American Journal of Obstetrics and Gynecology. 2000;182:358–363
  102. Mittendorf R, Roizen N, Maowad A, et al. Association between cerebral palsy and coagulase-negative staphylococci. Lancet. 1999;354:1875–1876
  103. Gibson CS, MacLennan AH, Goldwater PN, Dekker GA. Antenatal causes of cerebral palsy: associations between inherited thrombophilias, viral and bacterial infection, and inherited susceptibility to infection. Obstetrical & Gynecological Survey. 2003;58:209–220
  104. Thorngren-Jerneck K, Herbst A. Perinatal factors associated with cerebral palsy in children born in Sweden. Obstetrics and Gynecology. 2006;108:1499–14505
  105. Perlman JM. Intrapartum asphyxia and cerebral palsy: is there a link?. Clinics in Perinatology. 2006;33:335–353
  106. Bailey C, Steer PJ. Maternal temperature in labour. Fetal and Maternal Medicine Review. 2007;18:67–83
  107. Gleeson NC, Nolan KM, Ford MR. Temperature, labour, and epidural analgesia. Lancet. 1989;2:861–862
  108. Mercier FJ, Benhamou D. Hyperthermia related to epidural analgesia during labor. International Journal of Obstetric Anesthesia. 1997;6:19–24
  109. Fehder WP, Gennaro S. Immune alterations associated with epidural analgesia for labor and delivery. MCN. The American Journal of Maternal Child Nursing. 1998;23:292–299
  110. Kost-Byerly S, Tobin JR, Greenberg RS, et al. Bacterial colonization and infection rate of continuous epidural catheters in children. Anesthesia and Analgesia. 1998;86:712–716
  111. Frigoletto FD, Lieberman E, Lang JM, et al. A clinical trial of active management of labor. The New England Journal of Medicine. 1995;333:745–750
  112. Marx GF, Loew DA. Tympanic temperature during labour and parturition. British Journal of Anaesthesia. 1975;47:600–602
  113. Dashe JS, Rogers BB, McIntire DD, Leveno KJ. Epidural analgesia and intrapartum fever: placental findings. Obstetrics and Gynecology. 1999;93:341–344
  114. Gross JB, Cohen AP, Lang JM, et al. Differences in systemic opioid use do not explain increased fever incidence in parturients receiving epidural analgesia. Anesthesiology. 2002;97:157–161
  115. Goetzl L, Evans T, Rivers J, et al. Elevated maternal and fetal serum interleukin-6 levels are associated with epidural fever. American Journal of Obstetrics and Gynecology. 2002;187:834–838
  116. De Jongh RF, Vissers KC, Booij LH, et al. Interleukin-6 and perioperative thermoregulation and HPA-axis activation. Cytokine. 2003;21:248–256
  117. Thong WY, Strickler AG, Li S, et al. Hyperthermia in the forty-eight hours after cardiopulmonary bypass. Anesthesia and Analgesia. 2002;95:1489–1495
  118. Freischlag J, Busuttil RW. The value of postoperative fever evaluation. Surgery. 1983;94:358–363
  119. Garibaldi RA, Brodine S, Matsumiya S, Coleman M. Evidence for the non-infectious etiology of early postoperative fever. Infection Control. 1985;6:273–277
  120. Hobar PC, Masson JA, Herrera R, et al. Fever after craniofacial surgery in the infant under 24 months of age. Plastic Reconstructive Surgery. 1998;102:32–36
  121. Dionigi R, Dionigi G, Rovera F, Boni L. Postoperative fever. Surgical Infections. 2006;(7 Suppl 2):S17–S20
  122. Arons MM, Wheeler AP, Bernard GR, et al. Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Ibuprofen in Sepsis Study Group. Critical Care Medicine. 1999;27:699–707
  123. Kilpatrick MM, Lowry DW, Firlik AD, et al. Hyperthermia in the neurosurgical intensive care unit. Neurosurgery. 2000;47:850–855[discussion: 855–856]
  124. Barie PS, Hydo LJ, Eachempati SR. Causes and consequences of fever complicating critical surgical illness. Surgical Infections. 2004;5:145–159
  125. Circiumaru B, Baldock G, Cohen J. A prospective study of fever in the intensive care unit. Intensive Care Medicine. 1999;25:668–673
  126. Peres Bota D, Lopes Ferreira F, Melot C, Vincent JL. Body temperature alterations in the critically ill. Intensive Care Medicine. 2004;30:811–816
  127. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. The Journal of the American Medical Association. 1995;274:639–644
  128. Huckell VF, Staniloff HM, Britt BA, Morch JE. Electrocardiographic abnormalities associated with malignant hyperthermia susceptibility. Journal of Electrocardiology. 1982;15:137–141
  129. Carpenter J, Sander G, Newby N, Kendrick M. Phenytoin hypersensitivity presenting as postoperative fever. Neurosurgery. 1980;6:426–429
  130. Mackowiak PA. Drug fever: mechanisms, maxims and misconceptions. The American Journal of the Medical Sciences. 1987;294:275–286
  131. Tabor PA. Drug-induced fever. Drug Intelligence & Clinical Pharmacy. 1986;20:413–420
  132. Rutledge R, Sheldon GF, Collins ML. Massive transfusion. Critical Care Clinics. 1986;2:791–805
  133. Heddle NM. Pathophysiology of febrile nonhemolytic transfusion reactions. Current Opinion in Hematology. 1999;6:420–426
  134. Kalliafas S, Ziegler DW, Flancbaum L, Choban PS. Acute acalculous cholecystitis: incidence, risk factors, diagnosis, and outcome. The American Surgeon. 1998;64:471–475
  135. Wartenberg KE, Schmidt JM, Claassen J, et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Critical Care Medicine. 2006;34:617–623[quiz 624]
  136. Schwarz S, Hafner K, Aschoff A, Schwab S. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology. 2000;54:354–361
  137. Castillo J, Davalos A, Marrugat J, Noya M. Timing for fever-related brain damage in acute ischemic stroke. Stroke. 1998;29:2455–2460
  138. Albrecht RF, Wass CT, Lanier WL. Occurrence of potentially detrimental temperature alterations in hospitalized patients at risk for brain injury. Mayo Clinic Proceedings. 1998;73:629–635
  139. Diringer MN, Reaven NL, Funk SE, Uman GC. Elevated body temperature independently contributes to increased length of stay in neurologic intensive care unit patients. Critical Care Medicine. 2004;32:1489–1495
  140. Chatzipanteli K, Alonso OF, Kraydieh S, Dietrich WD. Importance of posttraumatic hypothermia and hyperthermia on the inflammatory response after fluid percussion brain injury: biochemical and immunocytochemical studies. Journal of Cerebral Blood Flow and Metabolism. 2000;20:531–542
  141. Kil HY, Zhang J, Piantadosi CA. Brain temperature alters hydroxyl radical production during cerebral ischemia/reperfusion in rats. Journal of Cerebral Blood Flow and Metabolism. 1996;16:100–106
  142. Lin B, Busto R, Globus MY, et al. Brain temperature modulations during global ischemia fail to influence extracellular lactate levels in rats. Stroke. 1995;26:1634–1638
  143. Globus MY, Ginsberg MD, Busto R. Excitotoxic index–a biochemical marker of selective vulnerability. Neuroscience Letters. 1991;127:39–42
  144. Takagi K, Ginsberg MD, Globus MY, et al. Effect of hyperthermia on glutamate release in ischemic penumbra after middle cerebral artery occlusion in rats. The American Journal of Physiology. 1994;267:H1770–H1776
  145. Suehiro E, Fujisawa H, Ito H, et al. Brain temperature modifies glutamate neurotoxicity in vivo. Journal of Neurotrauma. 1999;16:285–297
  146. Asai S, Zhao H, Kohno T, et al. Quantitative evaluation of extracellular glutamate concentration in postischemic glutamate re-uptake, dependent on brain temperature, in the rat following severe global brain ischemia. Brain Research. 2000;864:60–68
  147. Dietrich WD, Busto R, Halley M, Valdes I. The importance of brain tempeature in alterations of the blood-brain barrier following cerebral ischemia. Journal of Neuropathology and Experimental Neurology. 1990;49:486–497
  148. Morimoto T, Ginsberg MD, Dietrich WD, Zhao W. Hyperthermia enhances spectrin breakdown in transient focal cerebral ischemia. Brain Research. 1997;746:43–51
  149. Eguchi Y, Yamashita K, Iwamoto T, Ito H. Effects of brain temperature on calmodulin and microtubule-associated protein 2 immunoreactivity in the gerbil hippocampus following transient forebrain ischemia. Journal of Neurotrauma. 1997;14:109–118
  150. Chopp M, Knight R, Tidwell CD, et al. The metabolic effects of mild hypothermia on global cerebral ischemia and recirculation in the cat: comparison to normothermia and hyperthermia. Journal of Cerebral Blood Flow and Metabolism. 1989;9:141–148
  151. Busto R, Globus MY, Neary JT, Ginsberg MD. Regional alterations of protein kinase C activity following transient cerebral ischemia: effects of intraischemic brain temperature modulation. Journal of Neurochemistry. 1994;63:1095–1103
  152. Minamisawa H, Smith ML, Siesjo BK. The effect of mild hyperthermia and hypothermia on brain damage following 5, 10, and 15 minutes of forebrain ischemia. Annals of Neurology. 1990;28:26–33
  153. Dietrich WD, Alonso O, Halley M, Busto R. Delayed posttraumatic brain hyperthermia worsens outcome after fluid percussion brain injury: a light and electron microscopic study in rats. Neurosurgery. 1996;38:533–541[discussion: 541]
  154. Wass CT, Lanier WL, Hofer RE, et al. Temperture changes of ≥1°C alter functional neurologic outcome and histopathology in a canine model of a complete cerebral ischemia. Anesthesiology. 1995;83:325–335
  155. Baena RC, Busto R, Dietrich WD, et al. Hyperthermia delayed by 24 hours aggravates neuronal damage in rat hippocampus following global ischemia. Neurology. 1997;48:768–773
  156. Oliveira-Filho J, Ezzeddine MA, Segal AZ, et al. Fever in subarachnoid hemorrhage: relationship to vasospasm and outcome. Neurology. 2001;56:1299–1304
  157. Fernandez A, Schmidt JM, Claassen J, et al. Fever after subarachnoid hemorrhage: risk factors and impact on outcome. Neurology. 2007;68:1013–1019
  158. Azzimondi G, Bassein L, Nonino F, et al. Fever in acute stroke worsens prognosis. A prospective study. Stroke. 1995;26:2040–2043
  159. Hindfelt B. The prognostic significance of subfebrility and fever in ischaemic cerebral infarction. Acta Neurologica Scandinavica. 1976;53:72–79
  160. Reith J, Jorgensen HS, Pedersen PM, et al. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet. 1996;347:422–425
  161. Adams HP, Adams RJ, Brott T, et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke. 2003;34:1056–1083
  162. Broderick JP, Adams HP, Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1999;30:905–915

PII: S1521-6896(07)00108-5

doi: 10.1016/j.bpa.2007.11.001

Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 4 , Pages 669-694 , December 2008

Article Tools

* Image Usage & Resolution